OrthoPediatrics Corp. (KIDS)
USD 23.62
(-10.22%)
USD 23.62
(-10.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -8.38 Million USD | 20.08% |
| 2022 | -7.92 Million USD | -71.61% |
| 2021 | -7.19 Million USD | 50.65% |
| 2020 | -22.34 Million USD | -176.65% |
| 2019 | -4.51 Million USD | 34.92% |
| 2018 | -6.87 Million USD | -70.37% |
| 2017 | -4.03 Million USD | -26.39% |
| 2016 | -3.19 Million USD | 33.03% |
| 2015 | -4.76 Million USD | 15.35% |
| 2014 | -5.63 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -887 Thousand USD | 78.55% |
| 2024 Q1 | -4.69 Million USD | 25.18% |
| 2023 Q3 | 1.53 Million USD | 226.05% |
| 2023 FY | - USD | 20.08% |
| 2023 Q1 | -5.41 Million USD | -10.07% |
| 2023 Q2 | -1.21 Million USD | 77.52% |
| 2023 Q4 | -2.58 Million USD | -268.64% |
| 2022 FY | - USD | -71.61% |
| 2022 Q4 | -4.91 Million USD | -386.93% |
| 2022 Q3 | -1.01 Million USD | 77.9% |
| 2022 Q2 | -4.57 Million USD | -37.65% |
| 2022 Q1 | -3.32 Million USD | -34.41% |
| 2021 FY | - USD | 50.65% |
| 2021 Q2 | 137 Thousand USD | 104.18% |
| 2021 Q3 | -3.37 Million USD | -2564.96% |
| 2021 Q1 | -3.27 Million USD | 12.81% |
| 2021 Q4 | -2.47 Million USD | 26.86% |
| 2020 Q2 | -5.22 Million USD | -63.84% |
| 2020 Q3 | -209 Thousand USD | 96.0% |
| 2020 Q4 | -3.75 Million USD | -1696.65% |
| 2020 Q1 | -3.19 Million USD | -5.56% |
| 2020 FY | - USD | -176.65% |
| 2019 Q2 | -1.82 Million USD | 3.28% |
| 2019 FY | - USD | 34.92% |
| 2019 Q4 | -3.02 Million USD | -1191.88% |
| 2019 Q3 | -234 Thousand USD | 87.19% |
| 2019 Q1 | -1.88 Million USD | 2.38% |
| 2018 FY | - USD | -70.37% |
| 2018 Q1 | -3.76 Million USD | -5.96% |
| 2018 Q2 | -1.41 Million USD | 62.54% |
| 2018 Q3 | -480 Thousand USD | 65.98% |
| 2018 Q4 | -1.93 Million USD | -303.13% |
| 2017 Q3 | -776 Thousand USD | -3427.27% |
| 2017 Q1 | -342 Thousand USD | 87.39% |
| 2017 Q4 | -3.55 Million USD | -358.12% |
| 2017 FY | - USD | -26.39% |
| 2017 Q2 | -22 Thousand USD | 93.57% |
| 2016 Q4 | -2.71 Million USD | -5218.87% |
| 2016 FY | - USD | 33.03% |
| 2016 Q3 | 53 Thousand USD | -89.53% |
| 2016 Q2 | 506 Thousand USD | 148.7% |
| 2016 Q1 | -1.03 Million USD | 0.0% |
| 2015 FY | - USD | 15.35% |
| 2015 Q1 | -1.38 Million USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 37.859% |
| Cerus Corporation | -26.53 Million USD | 68.416% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 20.139% |
| Talis Biomedical Corporation | -66.04 Million USD | 87.31% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 49.739% |
| Inogen, Inc. | -45.67 Million USD | 81.652% |
| Spectral AI, Inc. | -12.26 Million USD | 31.651% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 82.427% |
| CVRx, Inc. | -38.73 Million USD | 78.361% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -137.557% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 30.776% |
| Orthofix Medical Inc. | -86.98 Million USD | 90.365% |
| Venus Concept Inc. | -26.11 Million USD | 67.905% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 83.161% |
| Bioventus Inc. | -23.07 Million USD | 63.671% |
| BrainsWay Ltd. | -2.31 Million USD | -262.657% |
| Envoy Medical, Inc. | -18.23 Million USD | 54.046% |
| electroCore, Inc. | -17.76 Million USD | 52.81% |
| IceCure Medical Ltd | -15.25 Million USD | 45.053% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 83.154% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 50.278% |
| MaxCyte, Inc. | -44.12 Million USD | 81.008% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 28.709% |
| Nexalin Technology, Inc. | -5.69 Million USD | -47.241% |
| PAVmed Inc | -75.74 Million USD | 88.935% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 84.41% |
| RxSight, Inc. | -41.03 Million USD | 79.577% |
| Sight Sciences, Inc. | -49.41 Million USD | 83.04% |
| SI-BONE, Inc. | -34.44 Million USD | 75.669% |
| TELA Bio, Inc. | -40.63 Million USD | 79.374% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 85.624% |
| Treace Medical Concepts, Inc. | -39 Million USD | 78.515% |
| LivaNova PLC | 39.01 Million USD | 121.481% |
| 908 Devices Inc. | -34.02 Million USD | 75.368% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 92.422% |
| Nemaura Medical Inc. | -7.28 Million USD | -15.012% |
| NeuroPace, Inc. | -22.83 Million USD | 63.296% |
| LENSAR, Inc. | -8.71 Million USD | 3.821% |
| Apyx Medical Corporation | -18.11 Million USD | 53.727% |
| Cutera, Inc. | -136.56 Million USD | 93.863% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -147.959% |
| BioSig Technologies, Inc. | -28.15 Million USD | 70.228% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 433.108% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 60.07% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 102.185% |
| Axonics, Inc. | 7.77 Million USD | 207.794% |
| Outset Medical, Inc. | -153.78 Million USD | 94.55% |
| IRIDEX Corporation | -7.44 Million USD | -12.527% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 91.456% |
| IRadimed Corporation | 20.8 Million USD | 140.292% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -3.957% |
| INVO Bioscience, Inc. | -6.88 Million USD | -21.816% |
| Telesis Bio, Inc. | -40.49 Million USD | 79.303% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 122.851% |
| Varex Imaging Corporation | 67.2 Million USD | 112.472% |
| Quipt Home Medical Corp. | 44.07 Million USD | 119.017% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 22.898% |
| Pulmonx Corporation | -55.09 Million USD | 84.787% |
| Dynatronics Corporation | -976 Thousand USD | -758.702% |
| Modular Medical, Inc. | -17.1 Million USD | 50.997% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 42.14% |
| Semler Scientific, Inc. | 23.58 Million USD | 135.529% |
| InMode Ltd. | 196.28 Million USD | 104.27% |
| Bruker Corporation | 599 Million USD | 101.399% |
| Cytosorbents Corporation | -28.81 Million USD | 70.91% |
| DexCom, Inc. | 916.7 Million USD | 100.914% |
| Align Technology, Inc. | 799.03 Million USD | 101.049% |
| Viveve Medical, Inc. | -20.61 Million USD | 59.349% |
| ZimVie Inc. | 91.07 Million USD | 109.203% |
| Movano Inc. | -29.12 Million USD | 71.224% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -90.132% |
| Nexalin Technology, Inc. | -5.69 Million USD | -47.241% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -137.557% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 95.694% |
| Profound Medical Corp. | -27.12 Million USD | 69.101% |
| Insulet Corporation | 323.6 Million USD | 102.59% |
| enVVeno Medical Corporation | -25.01 Million USD | 66.5% |
| Surmodics, Inc. | 1.18 Million USD | 805.471% |
| iCAD, Inc. | -6.56 Million USD | -27.662% |
| Nuwellis, Inc. | -16.35 Million USD | 48.759% |
| Biotricity, Inc. | -8.82 Million USD | 5.066% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 91.347% |
| Aethlon Medical, Inc. | -11.84 Million USD | 29.269% |
| InspireMD, Inc. | -20.91 Million USD | 59.921% |
| PAVmed Inc. | -75.74 Million USD | 88.935% |
| BIOLASE, Inc. | -15.13 Million USD | 44.64% |
| Beyond Air, Inc. | -59.03 Million USD | 85.802% |
| FONAR Corporation | 28.25 Million USD | 129.666% |
| AxoGen, Inc. | -13.32 Million USD | 37.117% |
| Vivani Medical, Inc. | -26.6 Million USD | 68.502% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 134.151% |
| Inari Medical, Inc. | 7.11 Million USD | 217.827% |
| UFP Technologies, Inc. | 72.74 Million USD | 111.521% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -147.535% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -36.144% |
| Tenon Medical, Inc. | -15.52 Million USD | 46.027% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 45.1% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 79.793% |
| AdaptHealth Corp. | -171.09 Million USD | 95.101% |
| Sintx Technologies, Inc. | -6.6 Million USD | -26.985% |
| NanoVibronix, Inc. | -3.43 Million USD | -143.988% |
| Quanterix Corporation | -38.08 Million USD | 77.996% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 22.898% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 28036.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 96.977% |
| TransMedics Group, Inc. | -7.6 Million USD | -10.233% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 61.493% |
| NeuroMetrix, Inc. | -7.09 Million USD | -18.112% |
| Hyperfine, Inc. | -47.06 Million USD | 82.191% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 85.626% |
| Biomerica, Inc. | -5.99 Million USD | -39.846% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1847.6% |
| AVITA Medical, Inc. | -39.56 Million USD | 78.819% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 8.633% |
| Silk Road Medical, Inc | -45.08 Million USD | 81.409% |